Outcomes of patients who stopped immunotherapy due to immune-related side effects
Immunotherapy has changed the way advanced renal cell carcinoma (RCC) [...]
ESMO 2021: TKI treatment breaks for advanced/metastatic kidney cancer – the STAR study
There is increasing interest in using treatment breaks to reduce [...]
Sutent treatment breaks may benefit people with advanced kidney cancer
A recent phase 2 study from American researchers based at [...]
